Corneal macular dystrophy: Clinical, histopathologic and ultrastructural features;Distrofia macular corneal: Características clínicas, histopatológicas y ultraestructurales

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 81, Issue 6, 2006, Pages 315-320

  Gulias Cañizo, Rosario ^a,b   Castaneda Diez R ^a   Gomez Leal A ^a   Klintworth, G K ^a   Rodriguez Reyes A A ^a  

^a HOSPITAL DR LUIS SÁNCHEZ BULNES   (Mexico)

^b Servicio de Patología Oftálmica   (Mexico)

Author keywords

Cornea; Corneal; Corneal dystrophy; Macular dystrophy; Stromal dystrophies

Indexed keywords

SULFOTRANSFERASE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONGENITAL CORNEA DYSTROPHY; CORNEA STROMA; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MALE; MUTATION; PATHOLOGY; SEX DIFFERENCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADULT; CORNEAL DYSTROPHIES, HEREDITARY; CORNEAL STROMA; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; SEX FACTORS; SULFOTRANSFERASES;

EID: 33750094117     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Becker M, Rohrschneider K, Tilgen W, Weber BH, Volcker HE. Familial juvenile macular dystrophy with congenital hypotrichosis capitis. Ophthalmologe 1998; 95: 233-240.
2. Akama TO, Nishida K, Nakayama J, Watanabe H, Ozaki K, Nakamura T et al. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet 2000; 26: 237-241.
3. Klintworth GK, Reed J, Stainer GA, Binder PS. Recurrence of macular corneal dystrophy within grafts. Am J Ophthalmol 1983; 95: 60-72.
4. El-Ashry MF, El-Aziz MM, Wilkins S, Cheetham ME, Wilkie SE, Hardcastle AJ et al. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy. Invest Ophthalmol Vis Sci 2002; 43: 377-382.
5. Aldave AJ, Yellore VS, Thonar EJ, Udar N, Warren JF, Yoon MK et al. Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in American patients with macular corneal dystrophy. Am J Ophthalmol 2004; 137: 465-473.
6. Hasegawa N, Torii T, Kato T, Miyajima H, Furuhata A, Nakayasu K et al. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy. Invest Ophthalmol Vis Sci 2000; 41: 3670-3677.
7. Kuchle M, Cursiefen C, Fischer DC, Shlotzer-Schrehardt U, Nauman GO. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty. Arch Ophthalmol 1999; 117: 528-531.
8. Davies Y, Fullwood NJ, Marcyniuk B, Bonshek R, Tullo A, Nieduszynski IA. Keratan sulphate in the trabecular meshwork and cornea. Curr Eye Res 1997; 16: 677-686.
9. Lang GK, Naumann GO. The frequency of corneal dystrophies requiring keratoplasty in Europe and the U.S.A. Cornea 1987; 6: 209-211.
10. Edward DP, Thonar EJ, Srinivasan M, Yue BJ, Tso MO. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism. Ophthalmology 1990; 97: 1194-1200.